» Articles » PMID: 37241232

Chronic Periodontal Infection and Not Iatrogenic Interference Is the Trigger of Medication-Related Osteonecrosis of the Jaw: Insights from a Large Animal Study (PerioBRONJ Pig Model)

Overview
Publisher MDPI
Specialty General Medicine
Date 2023 May 27
PMID 37241232
Authors
Affiliations
Soon will be listed here.
Abstract

: Antiresorptive drugs are widely used in osteology and oncology. An important adverse effect of these drugs is medication-induced osteonecrosis of the jaw (MRONJ). There is scientific uncertainty about the underlying pathomechanism of MRONJ. A promising theory suspects infectious stimuli and local acidification with adverse effects on osteoclastic activity as crucial steps of MRONJ etiology. Clinical evidence showing a direct association between MRONJ and oral infections, such as periodontitis, without preceding surgical interventions is limited. Large animal models investigating the relationship between periodontitis and MRONJ have not been implemented. It is unclear whether the presence of infectious processes without surgical manipulation can trigger MRONJ. The following research question was formulated: is there a link between chronic oral infectious processes (periodontitis) and the occurrence of MRONJ in the absence of oral surgical procedures? A minipig large animal model for bisphosphonate-related ONJ (BRONJ) using 16 Göttingen minipigs divided into 2 groups (intervention/control) was designed and implemented. The intervention group included animals receiving i.v. bisphosphonates (zoledronate, n = 8, 0.05 mg/kg/week: ZOL group). The control group received no antiresorptive drug (n = 8: NON-ZOL group). Periodontitis lesions were induced by established procedures after 3 months of pretreatment (for the maxilla: the creation of an artificial gingival crevice and placement of a periodontal silk suture; for the mandible: the placement of a periodontal silk suture only). The outcomes were evaluated clinically and radiologically for 3 months postoperatively. After euthanasia a detailed histological evaluation was performed. Periodontitis lesions could be induced successfully in all animals (both ZOL and NON-ZOL animals). MRONJ lesions of various stages developed around all periodontitis induction sites in the ZOL animals. The presence of MRONJ and periodontitis was proven clinically, radiologically and histologically. The results of this study provide further evidence that the infectious processes without prior dentoalveolar surgical interventions can trigger MRONJ. Therefore, iatrogenic disruption of the oral mucosa cannot be the decisive step in the pathogenesis of MRONJ.

Citing Articles

A retrospective case series on bisphosphonate related osteonecrosis of the jaw in 20 cats.

Hatunen S, Anderson J, Bell C, Campos H, Finkelman M, Shope B Front Vet Sci. 2024; 11:1436988.

PMID: 39247125 PMC: 11377274. DOI: 10.3389/fvets.2024.1436988.


Inflammation Can Be a High-Risk Factor for Mucosal Nonunion of MRONJ by Regulating SIRT1 Signaling When Treated with an Oncologic Dose of Zoledronate.

Zhu S, Cui Y, Zhang W, Ji Y, Li L, Luo S Drug Des Devel Ther. 2024; 18:2793-2812.

PMID: 38979400 PMC: 11229984. DOI: 10.2147/DDDT.S456811.


Editorial: Immunological processes in maxillofacial bone pathology.

Troltzsch M Front Immunol. 2024; 15:1394835.

PMID: 38545105 PMC: 10965781. DOI: 10.3389/fimmu.2024.1394835.


A novel investigational preclinical model to assess fluence rate for dental oral craniofacial tissues.

Sourvanos D, Zhu T, Dimofte A, Busch T, Lander B, Burrell J Photodiagnosis Photodyn Ther. 2024; 46:104015.

PMID: 38373469 PMC: 11139582. DOI: 10.1016/j.pdpdt.2024.104015.

References
1.
Fizazi K, Carducci M, Smith M, Damiao R, Brown J, Karsh L . Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study. Lancet. 2011; 377(9768):813-22. PMC: 3090685. DOI: 10.1016/S0140-6736(10)62344-6. View

2.
Sheiham A . Is the chemical prevention of gingivitis necessary to prevent severe periodontitis?. Periodontol 2000. 1998; 15:15-24. DOI: 10.1111/j.1600-0757.1997.tb00100.x. View

3.
Campisi G, Mauceri R, Bertoldo F, Bettini G, Biasotto M, Colella G . Medication-Related Osteonecrosis of Jaws (MRONJ) Prevention and Diagnosis: Italian Consensus Update 2020. Int J Environ Res Public Health. 2020; 17(16). PMC: 7460511. DOI: 10.3390/ijerph17165998. View

4.
Oz H, Puleo D . Animal models for periodontal disease. J Biomed Biotechnol. 2011; 2011:754857. PMC: 3038839. DOI: 10.1155/2011/754857. View

5.
Thumbigere-Math V, Michalowicz B, Hodges J, Tsai M, Swenson K, Rockwell L . Periodontal disease as a risk factor for bisphosphonate-related osteonecrosis of the jaw. J Periodontol. 2013; 85(2):226-33. PMC: 3972496. DOI: 10.1902/jop.2013.130017. View